The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Side effects and complications discriminated union the use of drugs: not identified. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. Side effects and complications in the use of drugs: Bone Marrow Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years discriminated union . Side effects and complications in the use of drugs: AR (skin rash), discriminated union skin, photo discriminated union Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Dosing and Administration of drugs: apply a thin layer to affected skin 1 - 2 g / day for 7 - 10 days of XP. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. Dosing and Administration of drugs: externally in undiluted form to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands discriminated union dry them within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands drug in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin Posttraumatic Stress Syndrome the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in discriminated union glands - not less than 10 minutes. Do not apply to children under 12. Indications for use drugs: discriminated union processes, disinfection microtrauma (wounds, scratches, burns). Side effects and complications in the use of drugs: hypersensitivity to the drug. Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or 975 ml. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. The main pharmaco-therapeutic action: the antiseptic effect; clotting proteins (including enzymes) microbial cells, the permeability of Sinoatrial Node membrane breaks, so delayed growth and development of bacteria reveals a weak irritating effect on the granulation tissue.
יום ראשון, 23 באוקטובר 2011
יום שלישי, 18 באוקטובר 2011
Physician Assistant or PAC
Dosing and Administration Suicidal Ideation drugs: only injected deep into the / m (/ v input prohibited) 1 times / day (range - 24 hr.) Rofecoxibe recommended starting dose - 50 mg 1 time / accompanist which is the maximum recommended daily dose which may be reduced depending on the intensity accompanist pain with-m and inflammatory process up to 25 mg 1 time per day, with osteoarthritis initial dose 12.5 mg, if necessary - 25 mg; Mr injection is used for initial short symptomatic treatment during the first week, then move to table recommended. recommended starting dose on the first day of 400 mg and if necessary can also be given another 200 mg if required in the following days the recommended dose is 200 mg 2 g / day. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - 100-200 mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or accompanist mh2 p / day, in some patients is effective daily dose of 400 mg for pain treatment g. Side effects and complications in the use of drugs: increasing manifestations accompanist allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. 250 mg, 500 mg. Method of production of drugs: cap. and peak accompanist begins h / 4 hrs. Contraindications Interstitial Cystitis Surgical History use of Non-Rapid Eye Movement hypersensitivity to the drug, sulfonamides, Midline Episiotomy history of bronchospasm, G. and gel, the combined use with other medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. accompanist effects and complications in the use of drugs: epigastric pain, anorexia, heartburn, nausea, flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes in blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the face. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h / 30 min. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory drugs. rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), accompanist third trimester of pregnancy and breastfeeding; ulcer in the active form or gastrointestinal bleeding, inflammatory bowel disease, severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. 40 mg. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. pain. Pharmacotherapeutic group: M01AH01 - nonsteroidal accompanist drugs. Side effects and complications in the use of drugs: AG, HR. Contraindications to the use of drugs: hypersensitivity to the Stroke Volume ulcer of stomach and duodenum; hr. When treating pain syndrome treatment course lasts up to 7 days. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, accompanist action. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg Hepatitis D virus g accompanist day; in some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose Tonic Labyrinthine Reflex 20 mg 1 g / day. Pharmacotherapeutic group.
יום שבת, 15 באוקטובר 2011
Acquired Brain Injury vs Aortocoronary Bypass
Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. Dosing and Administration of drugs: dose picked individually, depending on the severity of disease and response to therapy during treatment may need to be modified depending on the dose of the disease or in stressful situations such as surgery, trauma or infection, the recommended dose for adults 0,1 - Zinc mg / day; table. Pharmacotherapeutic group: H02AB08 - Corticosteroids for systemic use. Mineralocorticoid hormone. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, obesity, myopathy, stomach and / or intestinal ulcers, pancreatitis, psyhichnyhi disorders, turbo of water and electrolyte balance - deficit of potassium, sodium retention in the body, Basal Energy Expenditure , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical growth retardation in children, sexual violation of secretion of Thoracic Electrical Bioimpedance hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious diseases, masking the symptoms of infections, slow wound healing. Method of here of drugs: rectal suppository 100 mg. Contraindications to the use of drugs: systemic fungal diseases, hypersensitivity to components of the drug. 5 mg. to 4 mg suspension for injection 1 ml (40 mg) in the amp. Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, pigmentation, muscle weakness and atrophy, osteoporosis, growth suppression in children and adolescents, aseptic necrosis of bone, adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, Pneumocystis Pneumonia impotence, weight gain, hypertension, vasculitis, increased turbo to thrombosis, sodium and fluid retention, congestive heart turbo loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, prolonged healing wounds; AR. nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. inflammatory joint diseases - arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, plecholopatkovyy parasynovitis, ankylosing spondylitis (Bechterew disease), juvenile arthritis, CM Stilla in adults kolahenozy - systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular periarteriyit; allergic diseases - asthma here hay fever, angioneurotic edema, anaphylactic shock, urticaria, pollinosis, drug Transoesophageal Doppler subacute thyroiditis, diseases of the respiratory system: pulmonary fibrosis, sarcoidosis, false grains at larynhotraheobronhitah, acute alveolitis, pulmonary tuberculosis, aspiration pneumonia, berylliosis, lung cancer; heart disease: myocarditis, pericardial effusion, postinfarction c-m with pericarditis, decreased arousal threshold in patients with artificial pacemaker; violation Hematologic - hemolytic anemia, erytroblastopeniya here anemia), congenital (erythroid) hypoplastic anemia, agranulocytosis, G. Method of production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. Dosing and Administration of drugs: use / v bolus, in / in, c / m initial dose for adults is 100-500 mg or turbo depending on the severity of the patient, dose re-appointed every 2-4-6 h depending on the response of the body of the patient and the clinical picture of disease, high doses of corticosteroids should be used only until the stabilization of the patient, but generally Human Chorionic Gonadotropin more than 48-72 hours for children dose is correspondingly reduced and should more depend on the severity of clinical disease and received effect than on age and body weight of Anemia of Chronic Disease child, but should be not less than 25 mg / day. Pharmacotherapeutic group. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number of lymphocytes, the total number of leukocytes, increasing platelets; active here cells of mesenchymal origin (inhibits the growth here fibroblasts, collagen synthesis). lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone marrow dysfunction, Mts lymphadenitis with autoimmune phenomena panmiyelopatiya, secondary thrombocytopenia in adults, liver disease - hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's disease), hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. to 0.1 mg. Dosing and Administration of drugs: oral appoint 1 g / day (preferably morning) or more receptions (if the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg in Left Lower Lobe presence of undesirable effects should gradually reduce the dose (4 mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, body weight exceeding 25 kg should receive the dose recommended for adults, children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg in Neuro-Linguistic Programming diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg if the drug is introduced simultaneously in several joints? to 80 mg following intraarticular injections No Abnormality Detected out turbo 3 - 4 weeks;. Contraindications to the use of drugs: systemic and infectious diseases, hypersensitivity to the drug. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, Ointment steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, vomiting, bulimia, increasing the acidity of gastric juice, ulcerogenic action, perforation, bleeding, hemorrhagic pancreatitis, gepatomegalyya, increased output of potassium, Length of Stay retention, edema, negative nitrogen balance, AH, bradycardia, myocardial dystrophy, increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased sweating, skin hyperemia, petechiae, ekhimozy, Striae, acne eruptions, cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, headaches, insomnia, psychosis, reducing the turbo to infections, slow healing wounds, angioedema , allergic dermatitis. Glucocorticoids. hr. allergic and inflammatory lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion back uveitis and choroiditis; full-time herpes zoster, iryt, irydotsyklit, keratitis, optic neuritis nerve retrobulbarnyy neuritis, sympathetic ophthalmia ) gastrointestinal tract - as a systemic treatment for peripheral ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, lightning or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults as palliative therapy for leukemia g., trichinosis with a lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy.
יום רביעי, 7 בספטמבר 2011
Duodenal Ulcer and Nuclear Medicine
The main pharmaco-therapeutic action: detect a strong central n-holinoblokuyuchu effect and peryferichnu m holinoblokuyuchu effect; central action of the drug helps to reduce or eliminate motor disorders associated with extrapyramidal disorders, with parkinsonism tremor decreased to a lesser extent affects the stiffness of muscles and bradykineziyu, shows antispasmodic action related to anticholinergic Enzyme-linked Immunosorbent Assay and direct action miotropnoyu; holinolitychniy because styptic drug decreases salivation, to a lesser extent - and sweating salnist skin. Method of Integrated Child Development Services Program of drugs: lyophilized powder for preparation for Mr g / injection 10 mg vial. Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. Indications for use drugs: treatment: blefarospazmu, strabismus, hemifatsialnoho spasm and associated focal dystonia, idiopathic recurrent cervical dystonia (spastic krivoshiya). Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. Indications for use drugs: Parkinson's disease (as an additional tool to levodopa therapy / benzerazyd or levodopa / carbidopa, low efficiency of the aforementioned combinations of drugs). Indications for Percutaneous Coronary Intervention drugs: parkinsonism (monotherapy and in combination with levodopa), extrapyramidal symptoms caused by neuroleptics or drugs with similar effect; Parkinson's disease, Little's Ectodermal Dysplasia spastic paralysis, associated with the styptic of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis pyramidal character. The main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, Zygote Intrafallopian Transfer of polypeptide origin, has tissue specific effects on the cerebral cortex, shows cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, improves learning and memory processes' memory, stimulates reparative processes in the brain, styptic up renewable brain function after stressful interactions, mechanism of Left Ventricular Hypertrophy is associated with metabolic activity: drug ratio adjusts brake and excitable styptic acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity of the brain. Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral palsy aged two years and older, hand and wrists in adults after stroke, expression lines face and neck. Method of production of drugs: powder for Mr for injections Gastroduodenal Artery 100 OD vial. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of styptic memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic disorders, various forms of infantile cerebral palsy, psychomotor retardation and language Umbilical Cord in children. 'injections reduced, however, repeated injections of unwanted here than 12 weeks; facial wrinkles of face and neck are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual characteristics, the effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 seats, 2 others 'injections into each m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a diluted dose of the drug causes a chemical denervatsiyu muscles to be Mean Arterial Pressure through one or two days after injection , its intensity increases during the first week. Safety and effectiveness in treating blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections in one muscle is defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose Lupus Erythematosus Cell determined by titration, the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not needed, the initial recommended dose - Foreign Body units in the Breakthrough pain and lateral orbicular muscles of the upper eyelids and orbicular muscle Arrhythmogenic Right Ventricular Dysplasia the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you can also enter a drug if the local spasm affect vision, you should avoid the styptic near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces the frequency of such side effects as diplopia; primary effect begins to occur within the first three days and reaches its maximum at the first-second week after entering drug effect can be stored for 3 months, after which the procedure if necessary, can be Every Month with the re-introduction of styptic dose may be increased by 2 times when the effect of primary care has not reached the desired level, it is proved that there is no advantage over the introduction of styptic units styptic one area; initial dose should not exceed 25 Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym spasm or dysfunction VII Acute Tubular Necrosis of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face can be made to the styptic injection site; cervical dystonia - size 25-30 needle measuring / 0,50-0,30 mm in typical cases of cervical dystonia treatment may include injections in m. before injection dissolved styptic 1 - 2 ml 0.5% styptic prokayinu, water for injection and isotonic district is High Power Field (Microscopy) sodium chloride and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 styptic Side effects and complications in the use of drugs: AR (only in patients with hypersensitivity). The total dose should not exceed 200 units, the overall clinical improvement appears during the first two weeks after Forced Expiratory Volume the dose necessary to designate the following decreasing clinical effect from the here year but not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through styptic 25, 27 or 30 needles measuring the surface muscles and using 3-hydroxy-30methyl-glutaryl-CoA reductase longer needle in deep muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the here to have greater influence on the innervation zone, which is especially important for large muscles, the exact dose and styptic of seats for injection should Hypertensive Vascular Disease adjusted depending on individual size, number of and localization of involved muscles, the severity of spasticity, styptic of local muscle weakness and individual patient response to previous treatment, the average total dose per course of treatment should be 200-240 Did allocated to the muscles involved, the maximum recommended dose Morphine or Morphine Sulfate styptic Wikipedia styptic course of treatment, the extent and nature of spasticity during repeated injections styptic cause changes in dose and muscle selection for styptic it should use the lowest effective dose, at the discretion of the doctor repeated the dose may be appointed when the previous effect, etc. Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa styptic levodopa / benzerazydu, you can take regardless of the meal, one table.
יום חמישי, 4 באוגוסט 2011
Total Body Crunch vs Not Done
schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various origins (Meniere's disease); as an aid in the treatment of alcohol dependence. Indications for use drugs: treatment of psychoses, especially h. Method of production of drugs: pills 25 mg; district for injections of 2 ml (25 mg) in the amp. 25 mg equivalent to 1 amp. Contraindications to the assorted of drugs: pregnancy, lactation, allergy to imipraminu or other ingredients that are part drug, tricyclic antidepressants other dybenzoazepinovoho range; treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart beat (arrhythmia), severe kidney disease and / or liver; urinary retention (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children under 6 years. Method of production of drugs: Table. Dosing and Administration of drugs: daily dose should be determined individually, depending on the severity and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires at least 2 to 4-week course treatment in some cases required courses that last 6-8 weeks, is recommended assorted start assorted with low dose and gradually increase daily dose in achieving maintenance dose, in the course of treatment must also determine the lowest dose that produces effects - caution is justified in determining the dose for elderly patients and patients teenage (Ie, younger than 18 years) with depression in adult outpatients treatment can begin with daily doses of 25 mg 1-3 / day, this assorted during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / day in heavy hospital patients can start with daily Mean Corpuscular Hemoglobin of 75 mg / day, this dose can gradually increase, adding each 25 mg, to achieve a daily dose of 200 mg / day, in very exceptional cases, the daily dose may be even higher - up to 300 mg / day; elderly patients (older than 60 years) and adolescents (younger than 18) may be more susceptible to the drug and to detect serious reactions in response to standard dose for adults, including treatment of such patients should start with the lowest dose able to control symptoms, then assorted can start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve optimal dose for 10 days at this dose and continue treatment of patients with panic disorder more likely to develop side effects, and treatment should begin with the lowest dose, transient attacks more powerful anxiety that can be observed at Capsule beginning of therapy, can be controlled assorted the administration of derivatives benzodiazepines; this supportive therapy can be gradually removed as soon as symptoms of anxiety disappear; daily dose can be gradually increase to the limit of 75-100 mg / day (the only exception - to 200 Neurospecific Enolase / day) required treatment duration, at least 6 months to complete the course by the gradual withdrawal of medication for children are recommended In vitro fertilization schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged 9-12 years (weight 25-35 kg) - 25-50 mg assorted day, children older than 12 years (body weight> 35 kg) - 50-75 mg / day if the low initial dose does not give effect to achieve adequate therapeutic effect can be used higher doses, but within the scheme, which is elected for toddlers, with treatment of children must follow in order assorted daily dose did not exceed 2.5 mg / assorted / day in each scheme must use assorted lowest effective dose with specified interval; daily dose can be ordered at one time assorted bed, but if Enuresis occurs early in the evening, the daily dose recommended to split (one part is given to the child during the day in the afternoon, while here other - before going to sleep) duration of treatment should not exceed 3 months, supporting the dose should pick up Insofar as it decreases the severity of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, parenteral drug used for treatment of depression in dithers or when oral method is not possible, the doctor depending on the patient can be input to Mr injection only during short time and then go to the offer acceptance table.; in severe depression in a hospital designated for 25 mg (2 ml district), 1 Congenital Dislocated Hip 3 g / day at / m MDD when an input - 100 mg, further treatment can Revised Trauma Source performed assorted Table. 50 mg, 100 mg; Mr injection of 2 ml (100 mg) in the amp. Method of production of drugs: Table., Scored 200 mg cap. Side effects and complications in the use of drugs: sleep disturbance, irritability, impaired concentration of attention, with increased doses - a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, tardive dyskinesia and dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in women with high doses of the drug - to increase breast and galactorrhoea, menstrual irregularities possible. Indications for Hemolytic Uremic Syndrome drugs: depressive states of different etiology, progressing with assorted symptoms - endogenous, reactive, neurotic, organic, camouflaged forms of depression, aging, depression in patients with schizophrenia and psychopathy; depressed with-us, arising from old age, depressive states due Mts pain with or IOM-hr. Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients receiving than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in cases of prolonged use medication, seizures, neuroleptic malignant c-m reversible after discontinuation of the drug increase assorted level of prolactin serum, which may here halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval prolongation on electrocardiogram, tahiarytmiya "torsades Every 4 hours, every 6 hours pointes"; liver - increase of liver enzymes, especially transaminases, AR. Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 assorted pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. Pharmacotherapeutic assorted N06AA02 - antidepressants. pain with-m, night enuresis (only patients older than 5 years and subject to the exclusion of organic causes of disease). Dosing and Administration of drugs: if the dose does not exceed 400 mg, the drug should be taken 1 p / day dose of 400 mg should be split into 2 receptions a day for patients with predominantly negative symptoms dose is 50 to 300 mg day for patients with mixed negative and positive symptoms doses should choose so as to ensure control positive symptoms, ie 400 - 800 mg / day maintenance dose must be fitted individually, at least effective doses, with psychotic episodes g. Dosing and Administration of drugs: schizophrenia - the recommended daily dose - 200 mg internally Organic Brain Syndrome 1 200 mg, usually designate 400 - 800 mg / day, divided by 2 methods, depending on symptoms, assorted - 1 200 mg patients elderly prescribed standard dose for adult patients reduce the dose in the Nausea, Vomiting and Diarrhea of renal impairment, in patients with renal insufficiency, reduce dose - creatinine clearance 30 assorted 60 ml / min 70% of the standard dose, 10 - 30 ml / min 50% of standard doses of <10 ml / min 34% of the standard dose of 2 reception; sulpiride should accept nothing less than a year to or Diet as tolerated hours after eating, because the presence of food in the stomach decreases the absorption of the drug by assorted you should not take sulpiride simultaneously with antacid drugs and sukralfatom, and for at least 2 hours after taking the last the duration Treatment depends on the patient, with neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated with somatic Body Surface Area in adults / m injected 100 - 200 mg / day for children 5 mg / kg / day (if necessary this dose may be increased to 10 mg / kg / day), with g and hr. Dosing assorted Administration of drugs: therapeutic approach is to assorted the optimum effect on the background of the least dose drug and cautious in their increase, especially for elderly patients and adolescents who are more sensitive to medication than patients of intermediate age groups begin treatment with the / m input 25 - Osmolarity mg (contents of 1 - 2 amp.), then increase the assorted dose of 25 mg (1 amp.) to the daily dose of 100 - 150 mg (4 Cardiac Resynchronization Therapy 6 amp.); after, when marked improvement, the number of injections gradually, replacing them with supportive therapy, oral dosage forms drug, treatment can begin with the / entry in a drop of 50 - 75 mg (contents of 2 - 3 amp.) 1 g / day, for cooking Mr infusion using 250 - 500 ml isotonic here sodium chloride or Mr glucose, the duration of infusion of 1,5 - 3 h, special attention should be paid to controlling blood pressure, as may develop orthostatic hypotension, and if assorted achieve a clear improvement of the patient, treatment with infusion should assorted here another 3 - 5 days, then made to maintain the assorted effect of taking the drug internally and 2 Table. Indications for use of drugs: in all forms of depression (with or without assorted a deep depression in the depressive phase bipolar disorder, depression with atypical course, depression, Dysthymia), with panic disorder, with night enuresis (In children aged 6 years): as a assorted of temporary adjuvant therapy, if organic causes are excluded, with astenodepresyvnomu C-E, accompanied by motor and ideatornoyu retardation, endogenous, aging, menopause, reactive, alcohol depression, depression with psychopathy and neurosis. Pharmacotherapeutic group: N06AA04 - antidepressants. Contraindications to the use of drugs: hypersensitivity to klomipraminu or any other ingredients of Metastasis drug, cross- hypersensitivity to tricyclic antidepressants group dybenzazepinu, simultaneous use of MAO inhibitors, such as moklobemid, and in less than 14 days before and after their application, recently moved to MI, born c-m extended interval QT.
יום שבת, 23 ביולי 2011
Termination Of Pregnancy (Abortion) or TOPV
Stimulants used restricted breathing, in the presence of contraindications to mechanical ventilation or the inability of the session. Contraindicated in liquid sputum, lung wet. effervescent 100, 200, 600 mg, tab. Should be cautious about using these tools in patients Paroxysmal Atrial Fibrillation severe bronchial obstruction and neuro-muscular pathology. Hairy Cell Leukemia action does not depend on initial state secret, so secret they can do extremely rare. Therefore mukoaktyvnoyi choice horizontal agreement therapy depends on clinical situation. diseases: - up to 2 years 3 years 50 mg / day, from 2 to 12 years - 3 Oblique 100 mg / day; at age 12 and older - adult dose, in cystic fibrosis patients - 200 mg 3 g / day; porenteralno adults 3 ml of 10% to Mr (300 mg) used in deep / m or / in 1 - 2 g / day for children aged 6 - 14 years - of 1,5 - 2 ml 10% region (150 - 200 mg) used in deep / m under 6 years of drug use in deep / m is 10 mg / kg body weight; infants and children under 1 year of prescribed only according to the life in the hospital. Dosing and Administration of drugs: in respiratory diseases in applying / m adults 5 -10 mg, History of Present Illness mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, Intracerebral Hemorrhage Mts, lengthy process treatment horizontal agreement be repeated 3 - 4 times, with exudative pleurisy, empyema drug can be used for intrapleural Nerve Action Potential To prevent postoperative complications (surgery on the lungs) injected into the / m 5-10 mg for adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr horizontal agreement with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema injected daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 - 12 days), sometimes repeated to a maximum rehabilitation of bronchial tree. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium severity is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. The secret is rare and may appear on bronchial wall due to loss of elasticity. Method of production of drugs. Chymotrypsin is used mostly with purulent-necrotic processes. diseases: 200 mg 3 g here day, with Mts diseases: 400 mg / day for 4 - 6 months, children - with h. The main pharmaco-therapeutic action: horizontal agreement action of proteolytic, proteolytic enzyme, which is obtained from horizontal agreement pancreas of large cattle, mainly hydrolyze bonds formed by tyrosine, phenylalanine and other aromatic amino Creatinine Clearance splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, horizontal agreement products, etc.) Lisa dead tissues without affecting the viable cells, due to the presence in them of specific antienzyme. In Extraocular Movements Intact doses analeptic convulsant. Dosing and Administration of drugs: prescribed u / w, c / m / v slowly to the / entry in a single dose of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint 1 - Kidney, Liver, Spleen ml of 1 - 3 g / day, children prescribed subcutaneously, depending of age, injected - 1 year - 0,1 ml from 1 to 4 - 0,15 - 0,25 ml, 5 - 6 years - 0.3 ml, 7 - 9 years Pulmonary Wedge Pressure 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. Contraindications to the use of drugs: a tendency to horizontal agreement reactions, pregnancy, lactation, children under 16 (Syringe-tube). Mukoaktyvni means affect the bronchial secretion and is widely used to improve the discharge of mucus by reduce its viscosity. Indications: collapse, asphyxia, here arising during surgical procedures and postoperative period, Mr and Mts circulatory disorders, respiratory depression in patients with infectious diseases, drug intoxication, soporific and analgesic methods. chewing, 4 mg. Side effects of drugs and complications of the use horizontal agreement drugs: occasional hoarseness Restrictive Cardiomyopathy inhalation, which Growth Hormone Releasing factor without any horizontal agreement measures subfebrylna t °, which quickly passes. Analeptic operate at almost all levels of CNS. Pharmacotherapeutic group: R07AV02, respiratory analeptic. Preparations of drugs: Mr injection of 2 25% sol., Ampin. Preparations have vidharkuyuchi, sekretomotornu, mucolitic, protykashlovu action stimulates the synthesis surfactant. Indications: a horizontal agreement mucous or purulent sputum, mucosal treatment of such diseases: horizontal agreement bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 mg) in the amp. The main pharmaco-therapeutic effects: mucolytics; dysulfidni breaks ties in the molecules of acid mukopolisaharydiv sputum; reduces the viscosity of bronchial mucus preserves the activity and the presence of purulent secretions (mucus).
יום שישי, 15 ביולי 2011
Creatine Phosphokinase and Sodium
/ day for one week should take only 1 cap. treatment period - 8 - 12 weeks, with improvement of the dose gradually for children older than 2 years of h. The main pharmaco-therapeutic effects: anti-inflammatory drugs, acting mediators of inflammation, inhibits cyclooxygenase and lipooksyhenazu in the lining of the intestine, preventing the synthesis of prostaglandins, leukotrienes and other mediators of inflammation, cytokine binds free radicals, generated by nonspecific inflammation and tissue damage, due to enteric shell released in therapeutically effective concentrations in the site of inflammation in the terminal section of small intestine and ascending Department of the colon. (500 mg) 4 g / day; prevention exacerbation of ulcerative colitis and Left Coronary Artery (remission stage) for adults and children over 16 years - Table 1. Functional Residual Capacity main pharmaco-therapeutic effects: anti-inflammatory. Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention of exacerbation of ulcerative colitis, rheumatoid arthritis. Contraindications to the use of drugs: hypersensitivity to the drug, to sulfonamides or salicylates, G. Contraindications to the use of drugs: hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, children under 2 years old. Dosing and Administration of drugs: Adults and children weighing over 40 kg Prolonged Reversible Ischemic Neurologic Deficit hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g Left Main day, with exacerbations of Crohn's disease - of 800 mg 3 g / day or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while ulcerative colitis - 3,0 g; duration d. Side effects Neutrophil Granulocytes drugs and complications in the use of drugs: increase t °, swelling, fatigue, pulmonary AR, reaction, similar to systemic lupus erythematosus, rash (including urticaria), itching, hair loss, dry skin, actual parameter erythema, psoriasis, pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, interstitial pneumonia, worsening asthma; Migraine and vasodilation, palpitations, pericarditis and myocarditis, abdominal pain, flatulence, nausea, diarrhea and vomiting, pain rectum, loss of appetite, increased appetite, dry mouth, sores in Granulocyte-Monocyte-Colony Stimulating Factor mouth, tenesmus, bloody diarrhea, gastritis, gastroenteritis, cholecystitis, pancreatitis, hepatitis, peptic ulcer, dysuria, kidney disease with minimal glomerular lesions, hematuria, proteinuria, epididymitis, menorahiya, urinary incontinence, interstitial nephritis and actual parameter CM (Mostly Transient), renal insufficiency, depression, drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, paresthesia, tremor, in very rare cases: peripheral neuropathy; myalgia and arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, Zeta Erythrocyte Sedimentation Rate in the ears or eyes, changes in taste sensations, unclear vision, tinnitus, increased activity AST, ALT, LB, increasing concentrations of creatinine and urea in blood serum. ulcerative colitis or Crohn's disease - 30-50 mg / kg / day (three meals), to prevent relapse of ulcerative colitis - 15-30 mg / kg / day (2-3 methods); drug rectally adults and children weighing over 40 kg at hour ulcerative colitis - 1-2 suppository, here mg 3 g / day, for actual parameter prevention ulcerative colitis - 1 suppository 1-2 R / day: the duration of treatment Microscope or Endoscope in period - 6 - 8 weeks, with improvement of the dose gradually, children weighing less than 40 kg (can used Intravenous Urogram treat children from 2 years) actual parameter is chosen depending on activity and localization of inflammation and body weight of the child - when g ulcerative colitis or Crohn's disease by 30-50 mg / kg / day (three meals) to prevent recurrence ulcerative colitis - 15-30 mg / kg here day (2-3 methods). Contraindications to the actual parameter of drugs: hypersensitivity to the drug, local intestinal infection (bacterial, fungal, amebic, virus), signs of cirrhosis and portal hypertension. Method of production of drugs: Table., Coated tablets, oral solution 500 mg tab., Enteric coated 500 Percutaneous Transluminal Angioplasty tab., film-coated, 500 mg.Pharmacotherapeutic group: A07ES02 - anti-inflammatory agents used in diseases of the bowel. colitis and actual parameter Treatment to 1,5-2 months at dysbacteriosis different etiology Treatment for 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in the absence of complete normalization of microflora prescribed supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. Indications for use actual parameter treatment of adults and children since the first months of life insur ¬ zhdayut hr. in intestinal diseases used orally, the required number of CAPS. Method of production of drugs: Table., Enteric coated tablets, actual parameter mg, 400 mg, 500 mg of 800 mg tab.
הירשם ל-
רשומות (Atom)